If your child has been diagnosed with IgA vasculitis—a condition that causes inflammation in blood vessels—you may be worried about whether it will affect their kidneys. New research offers some hope: scientists have found a simple blood test that can better predict which children are at risk of developing kidney problems.
What is IgA vasculitis? IgA vasculitis is an inflammatory condition where the immune system attacks small blood vessels. While some children show kidney involvement right away, others develop kidney problems weeks or months later. This unpredictability has made it challenging for doctors to know which children need closer monitoring or more aggressive treatment.
What did the researchers discover? A team analysed blood samples from 337 children with IgA vasculitis over six months. They measured five special proteins (called cytokines) that reflect how active the immune system is: IL-6, TNF-α, IL-17A, IL-18, and IL-23. When combined into a score called the cytokine augmentation score (CAS), these measurements were remarkably good at predicting which children would develop kidney disease.
The key finding: children with higher cytokine scores were nearly three times more likely to develop nephritis (kidney inflammation) within six months. Even more impressive, adding this cytokine test to routine clinical assessments improved doctors' ability to identify at-risk children from 72% accuracy to 80% accuracy.
Why does this matter for Singapore families? In Singapore and across Asia, IgA vasculitis is one of the most common types of vasculitis in children. Early identification of children at risk allows paediatricians to monitor kidney function more closely and start preventive treatments sooner. This can reduce the likelihood of long-term kidney damage.
Currently, doctors rely on clinical signs (like blood pressure and urine findings) and general inflammation markers. This new test adds a precision layer, helping doctors move away from a one-size-fits-all approach to personalised risk assessment. For parents, this means potentially fewer unnecessary hospital visits for low-risk children and better-targeted care for those who truly need it.
What happens next? The researchers note this is an early-stage finding from one hospital. Before this test becomes routine in Singapore clinics, it needs to be validated in other centres with diverse patient populations, and the blood test itself needs standardisation. However, the results are promising enough that your child's doctor may discuss this test during follow-up appointments.
Questions to ask your doctor: If your child has IgA vasculitis without kidney involvement at diagnosis, it's reasonable to ask whether cytokine testing might be available to better assess their individual risk. Understanding your child's specific risk profile can help you and your doctor create the best monitoring and treatment plan.